BuzzeoPDMA's optimally located sample distribution saves up to 30% on logistics costs
A fairly straightforward change in how samples are warehoused and shipped has resulted in a claimed up to 30% reduction in sample distribution costs for some clients, according to BuzzeoPDMA, a Cegedim company, in a recent announcement. By shifting distribution from the Middle Atlantic region to Memphis, TN, the company is able to effect the cost reduction. Key savings are derived from moving to more ground transportation rather than overnight air service; the Memphis location allows for more of the continental US to be reached within three days by ground, the usual delivery period specified by its pharma clients, says Paul Hamby, Senior Director, Compliance Solutions, at the company.
“The three-day limit is especially relevant for pharma companies engaged in direct-to-physician sampling programs,” notes Hamby. The central US location also enables carriers to receive and ship orders later in the day. Logistics providers have long known the value of the central US location; within Tennessee, Kentucky and Indiana, FedEx and UPS have major hubs, and many wholesalers and distributors have distribution centers there. But its value for economizing on sample-distribution programs appears to have been overlooked.
BuzzeoPDMA provides auditing, PDMA reconciliation, inventory, and compliance training for sample programs in addition to advising on logistics. The company also works with Invistics, a major supply-chain software vendor, to perform sampling optimization programs.
Sampling, today, has its challenges, both on regulatory and technology fronts and as a business practice. Says Hamby, “Direct to physician, e-sampling and other ‘alternative’ sampling programs are being looked at by most pharma marketers, but for the foreseeable future, there will be a place for face-to-face delivery of samples by reps,” Hamby says.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.